AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 170 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $234,000 | -31.0% | 4,921 | -10.5% | 0.00% | 0.0% |
| Q3 2018 | $339,000 | -8.9% | 5,500 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $372,000 | +24.4% | 5,500 | -0.3% | 0.00% | +50.0% |
| Q1 2018 | $299,000 | -9.4% | 5,515 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $330,000 | +23.1% | 5,515 | +0.0% | 0.00% | +50.0% |
| Q3 2017 | $268,000 | -7.3% | 5,513 | +0.2% | 0.00% | -33.3% |
| Q2 2017 | $289,000 | +16.1% | 5,500 | 0.0% | 0.00% | +50.0% |
| Q1 2017 | $249,000 | +19.7% | 5,500 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $208,000 | 0.0% | 5,500 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $208,000 | – | 5,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 906,317 | $16,078,000 | 4.88% |
| Asymmetry Capital Management, L.P. | 85,834 | $1,523,000 | 3.39% |
| March Altus Capital Management LP | 30,962 | $549,000 | 3.23% |
| DAFNA Capital Management LLC | 165,669 | $2,939,000 | 2.92% |
| Partner Investment Management, L.P. | 49,726 | $882,000 | 1.33% |
| Boulegeris Investments, Inc. | 93,320 | $1,655,000 | 1.27% |
| PFM Health Sciences, LP | 2,218,198 | $39,351,000 | 1.11% |
| NORTHPOINTE CAPITAL LLC | 443,125 | $7,861,000 | 1.02% |
| HARVEY CAPITAL MANAGEMENT INC | 121,850 | $2,161,000 | 0.86% |
| Granite Point Capital Management, L.P. | 70,000 | $1,242,000 | 0.85% |